CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,320,469
- in 18 filings, $12.5M under 10b5-1 plans
Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blum Robert I −$9.7M President & CEO sold 34% of stake
- Malik Fady Ibraham −$1.3M EVP Research & Development sold 12% of stake
- Hessekiel Jeffrey −$795K Chief Legal & Admin Officer sold 14% of stake
- Callos Andrew −$702K EVP, Chief Commercial Officer sold 15% of stake
- PARSHALL B LYNNE −$631K Director sold 63% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-10 | Kaye Edward M. MD Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-05-10 | HENDERSON JOHN T Director | Grant or award | +5,000 | 30,420 | ||
| 2023-05-10 | HENDERSON JOHN T Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-05-10 | Harrington Robert Arthur Director | Grant or award | +5,000 | 10,551 | ||
| 2023-05-10 | Harrington Robert Arthur Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-05-10 | COSTA SANTO J Director | Grant or award | +5,000 | 15,000 | ||
| 2023-05-10 | COSTA SANTO J Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-05-10 | Bhanji Muna Director | Grant or award | +5,000 | 16,031 | ||
| 2023-05-10 | Bhanji Muna Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-05-03 | Malik Fady Ibraham EVP Research & Development | Exercise or conversion 10b5-1 | +7,000 | $7.96 | $56K | 174,183 |
| 2023-05-03 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −7,000 | $40.00 | $280K | 167,183 |
| 2023-05-03 | Malik Fady Ibraham EVP Research & Development | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −7,000 | 74,322 | ||
| 2023-04-28 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +12,500 | $9.65 | $121K | 453,558 |
| 2023-04-28 | Blum Robert I President & CEO | Sale 10b5-1 | −12,500 | $37.68 | $471K | 441,058 |
| 2023-04-28 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −12,500 | 83,191 | ||
| 2023-04-14 | Blum Robert I President & CEO | Exercise or conversion 10b5-1 | +12,500 | $9.65 | $121K | 453,558 |
| 2023-04-14 | Blum Robert I President & CEO | Sale 10b5-1 | −12,500 | $35.61 | $445K | 441,058 |
| 2023-04-14 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −12,500 | 95,691 | ||
| 2023-04-13 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −4,000 | $34.21 | $137K | 167,183 |
| 2023-04-03 | Harrington Robert Arthur Director | Grant or award | +298 | $37.71 | $11K | 5,551 |
Page 42 of 45 · 885 trades